Partner
Ian Edvalson is a partner in the life sciences commercial and technology transactions practice at Wilson Sonsini Goodrich & Rosati’s Palo Alto office and a former member of the firm’s board of directors. He advises public and private biopharmaceutical, medtech, and life sciences companies—both in the U.S. and internationally—on the full range of transactions that support the discovery, development, supply, and commercialization of their products, technologies, and services.
Ian has deep experience structuring and negotiating strategic alliances, joint ventures, and other complex collaborations for the development and commercialization of pharmaceutical and related products. He regularly counsels clients on maximizing business value and enabling long-term growth through licensing, asset acquisitions, and research and development agreements.
With more than 30 years of combined legal and business experience—including time leading corporate and business development at Third Wave Technologies, a publicly traded genomics company—Ian brings a practical, strategic perspective to every engagement. He works closely with clients to define business objectives and execute mission-critical transactions that shape the trajectory of their companies.